Author: Chamnanchanunt, Supat; Fucharoen, Suthat; Umemura, Tsukuru
Title: Circulating microRNAs in malaria infection: bench to bedside Cord-id: gse1k0wh Document date: 2017_8_15
ID: gse1k0wh
Snippet: Severe malaria has a poor prognosis with a morbidity rate of 80% in tropical areas. The early parasite detection is one of the effective means to prevent severe malaria of which specific treatment strategies are limited. Many clinical characteristics and laboratory testings have been used for the early diagnosis and prediction of severe disease. However, a few of these factors could be applied to clinical practice. MicroRNAs (miRNAs) were demonstrated as useful biomarkers in many diseases such a
Document: Severe malaria has a poor prognosis with a morbidity rate of 80% in tropical areas. The early parasite detection is one of the effective means to prevent severe malaria of which specific treatment strategies are limited. Many clinical characteristics and laboratory testings have been used for the early diagnosis and prediction of severe disease. However, a few of these factors could be applied to clinical practice. MicroRNAs (miRNAs) were demonstrated as useful biomarkers in many diseases such as malignant diseases and cardiovascular diseases. Recently it was found that plasma miR-451 and miR-16 were downregulated in malaria infection at parasitic stages or with multi-organ failure involvement. MiR-125b, -27a, -23a, -150, 17–92 and -24 are deregulated in malaria patients with multiple organ failures. Here, the current findings of miRNAs were reviewed in relation to clinical severity of malaria infection and emphasized that miRNAs are potential biomarkers for severe malaria infection.
Search related documents:
Co phrase search for related documents- acidosis patient and lung injury: 1
- activity assay and acute ards respiratory distress syndrome: 1, 2, 3
- activity assay and low protein: 1
- activity assay and lps induce: 1, 2
- activity assay and luciferase activity assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activity assay and lung injury: 1, 2, 3
- acute ards respiratory distress syndrome and liver spleen: 1
- acute ards respiratory distress syndrome and low protein: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lps induce: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung vascular inflammation: 1, 2, 3
- liver spleen and low protein: 1, 2
- liver spleen and lung injury: 1, 2
- liver spleen and lung vascular inflammation: 1
- low protein and luciferase activity assay: 1
- low protein and lung injury: 1, 2, 3, 4, 5, 6
- lps induce and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- lps induce lung injury and lung injury: 1, 2
- lung injury and lytic replication: 1
Co phrase search for related documents, hyperlinks ordered by date